Neuroscience 2021

Karen David currently oversees the Circuits and Integrated Approaches portfolio of the BRAIN initiative. She joined the Systems and Cognitive Neuroscience cluster in 2013. Over the years, she has served the BRAIN Initiative in various capacities, including as Project Officer ... Scientific Review Officer, and Program Analyst to her current role as Program Director. Karen has also worked on various special projects including coordinating the review activities of the Biospecimen Repository Acquisition Committee (BRAC) for the Parkinson's Disease Biomarkers Program. Before joining extramural research, Karen did her postdoctoral fellowship in Molecular Biology and Genetics at Johns Hopkins School of Medicine. She earned a B.S. from the University of the Philippines and a Ph.D. in Cellular and Molecular Medicine from the Johns Hopkins University School of Medicine.

Dr. Kristin Dupre serves as a Scientific Content and Communication Strategist in the Office of Scientific Liaison (OSL) at the National Institute of Neurological Disorders and Stroke (NINDS). OSL aims to provide a seamless flow of information on NINDS research advances and ... initiatives to various stakeholders including scientific and academic communities, as well as policy-makers, patients, and the public. OSL manages the NINDS website, an important tool in broadly conveying this information. Major components of Dr. Dupre's work involve the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, which seeks to revolutionize our understanding of the human brain, and the BRAIN Initiative Alliance (www.braininitiative.org), a group of federal and non-federal participants whose mission is to coordinate and facilitate communications related to the BRAIN Initiative. Dr. Dupre is also an active participant in the NINDS Diversity Workgroup and the NIH Child Care Board. Prior to joining OSL, Dr. Dupre was an intramural postdoctoral fellow and Research Fellow in the laboratory of Dr. Judith Walters in the Neurophysiology Pharmacology Section of NINDS. She earned her B.S. in Psychology from Le Moyne College (Syracuse, NY) and her M.S. in Psychology and Ph.D. in Behavioral Neuroscience from Binghamton University (State University of New York), where she studied the neural mechanisms of dyskinesia in a rat model of Parkinson's disease using a variety of pharmacological, biochemical, neuromolecular, and behavioral techniques

Dr. Hsiao Yu (Christina) Fang is a Scientific Program Manager in the NINDS Systems and Cognitive Neuroscience Cluster. She earned her B.S. from National Tsing Hua University, and a Ph.D. in Genetics from the University of Cambridge. Under the guidance of Prof. Alfonso ... Martinez-Arias at Cambridge, she studied the role of Wingless and Notch signaling in the Drosophila midgut. She then joined the laboratory of Dr. Edward Giniger at NINDS as a postdoctoral fellow, where she used a novel 3D live imaging system to study neuronal growth. Dr. Fang provides scientific support for the Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative, Helping to End Addiction Long-termSM (HEAL) Initiative, Parkinson Disease Biomarker Program (PDBP), and other trans-NIH and interagency committees.

Dr. Jim Gnadt, NINDS Program Director in Systems and Computational Neuroscience and Team Lead for the NIH BRAIN Integrative and Quantitative Approaches, has worked in systems and cognitive neuroscience and neuroengineering for over 35 years. He has held his current position at ... NINDS, the neurology institute of NIH, since 2008, and has been a principal in the NIH BRAIN Initiative since its inception in 2014 where he co-leads the team of trans-NIH Program Directors in the 'understanding circuits' part of the initiative. Dr. Gnadt manages a diverse NIH funding portfolio in systems and computational neuroscience, including experimental programs in integrated, team-science approaches and in intracranial opportunities for investigative human neuroscience. In collaboration with NIH review offices, Dr. Gnadt has developed tools to understand the precision of NIH review scoring and methods to convey its margins of uncertainty. Prior to taking the position at NINDS, Dr. Gnadt was an NIH-funded investigator since 1984, working on sleep physiology related to narcolepsy, quantitative neurophysiologic approaches in cognitive neuroscience, systems engineering to understand neural circuit dynamics, and neurological etiologies of eye behavior pathologies. Facilitating translation of curiosity-driven, fundamental biology into human impacts remains the focus of Dr. Gnadt's efforts at the NIH.

Dr. Nina Hsu is as a Health Science Policy Analyst in the Office of Scientific Liaison at the National Institute of Neurological Disorders and Stroke (NINDS) at NIH, where she helps to provide a seamless flow of information on NINDS research advances and initiatives to various ... stakeholders including scientific and academic communities, as well as policy-makers, patients, and the public. A major component of Dr. Hsu's work involves strategic coordination and communication of the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. Dr. Hsu began working at NIH as an AAAS Science and Technology Policy fellow in 2017. Prior to the fellowship, she worked as a post-doctoral fellow at the University of Maryland, College Park. She received her Ph.D. in neuroscience from the University of Pennsylvania and her B.S. in psychology and neuroscience from Duke University.

President & CEO of StressMarq Biosciences Inc., a research reagent company with primary product lines in neurodegenerative diseases and cellular stress based in Victoria (BC), Canada. Successful Senior Scientific Business Executive with demonstrated expertise growing markets ... revenues, product pipelines and expanding technical organizations into new business opportunities. Educational and business management experience in global markets, with quantified success in moving technical businesses into new international arenas. Author of numerous peer-reviewed articles, and holder of several patents.

Dr. Marshall is an Assistant Professor in the department of Biological and Biomedical Sciences at North Carolina Central University in Durham, NC. He was previously in the Basic Pharmaceutical Science Department in High Point University's Fred Wilson School of Pharmacy. He ... received his undergraduate degree from the University of Florida and his doctorate in pharmaceutical sciences from the University of Kentucky. Throughout his academic career, his research has focused on how alcohol abuse fundamentally changes the brain increasing the susceptibility for addiction.

Dr. Paul J. Mathews received his bachelors degree from the University of Oregon where he studied invertebrate behavioral plasticity in the lab of Dr. Nathan Tublitz. He received his Ph.D. in neuroscience from the University of Texas at Austin under the mentorship of Dr. Nace ... Golding. Dr. Mathews work focused on understanding how the biophysical properties of specific voltage-gated ion channels in an auditory brainstem nuclei contribute to their capacity to make sub-millisecond computations necessary for low frequency sound localization. For the past several years Dr. Mathews has been working at UCLA under the mentorship of Dr. Tom Otis where he is currently working to uncover the cerebellar circuit mechanisms that underlie motor learning and memory. To do this Dr. Mathews is utilizing a multifaceted approach that includes both in vitro and in vivo electrophysiology, optogenetics, advanced optics, histology, and behavioral manipulations to make links between cerebellar circuit activity and motor output in rodent models. He is currently on the job market looking for a tenured track assistant professor position.